202. Metabolic Osteoarthritis: How Fat Tissue Talks to Your Joints

In this episode, Dr. Darsh Shah and Dr. Altamash Raja explore the emerging concept of metabolic osteoarthritis and the growing evidence linking joint degeneration to obesity, insulin resistance, inflammation, and metabolic syndrome. They break down novel research on GLP-1 medications and metformin, discuss how excess adipose tissue may contribute to joint damage, and explain why treating metabolic health could become an important part of osteoarthritis care in the future. TOPICS COVERED • Is osteoarthritis a metabolic disease? • The concept of metabolic osteoarthritis (MetS-OA) • How obesity, insulin resistance, and inflammation affect joint health • GLP-1 medications, weight loss, and osteoarthritis outcomes • Metformin and the future of disease-modifying treatments • Why strength training and muscle preservation matter for joint longevity RESOURCES & LINKS MENTIONED • STEP 9 Trial – Semaglutide and Osteoarthritis (https://www.nejm.org/doi/full/10.1056/NEJMoa2403664) • Effect of Metformin on Knee Osteoarthritis Pain in Patients With Overweight or Obesity (https://pubmed.ncbi.nlm.nih.gov/40274279/) • Metabolic Syndrome Meets Osteoarthritis (https://www.nature.com/articles/nrrheum.2012.135) • HOMA-IR Calculator (https://www.mdcalc.com/calc/3120/homa-ir-homeostatic-model-assessment-insulin-resistance) Ready to stop guessing and start performing? Dr. Raja is now seeing patients through his telemedicine practice — limited founding member spots available at refininghealthrx.com.
EPISODE DESCRIPTION
Is arthritis really just wear and tear? Dr. Altamash Raja and Dr. Darsh Shah make the case for metabolic osteoarthritis — the phenotype where fat tissue drives joint inflammation through hormones, not load. They cover the semaglutide and metformin trials, new weight-independent cartilage data, and how to spot the metabolic-OA patient in clinic. The takeaway: treat the disease, not just the symptom.
TOPICS COVERED
Reframing OA from "wear and tear" to a disease with a distinct metabolic phenotype
The OA phenotypes — age-related, post-traumatic, inflammatory, malalignment, pain-sensitization, and metabolic syndrome OA
The hand-OA clue: why obesity links to arthritis even in joints that bear no weight
New drug evidence — semaglutide (STEP 9), metformin (JAMA), and weight-independent cartilage protection in mice
How adipokines, insulin resistance, AGEs, and Hoffa's fat pad drive joint inflammation
Clinic application: identifying the MetS-OA patient, which labs to order, and the muscle-loss risk of rapid weight loss
RESOURCES & LINKS MENTIONED
Studies
Zhuo et al., "Metabolic syndrome meets osteoarthritis," Nature Reviews Rheumatology (2012) (https://www.nature.com/articles/nrrheum.2012.135)
STEP 9 trial — semaglutide 2.4 mg in obesity and knee OA, NEJM (2024) (https://www.novonordisk-us.com/media/news-archive/news-details.html?id=171970)
Pan et al., "Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity," JAMA (2025) (https://jamanetwork.com/journals/jama/fullarticle/2833338)
Semaglutide, weight-loss-independent OA mechanism, Cell Metabolism (2026) (https://www.cell.com/cell-metabolism/abstract/S1550-4131(26)00008-2) Concepts & tools
Osteoarthritis (https://en.wikipedia.org/wiki/Osteoarthritis) · Metabolic syndrome (https://en.wikipedia.org/wiki/Metabolic_syndrome)
WOMAC (https://en.wikipedia.org/wiki/WOMAC) · Kellgren–Lawrence grading (https://en.wikipedia.org/wiki/Kellgren%E2%80%93Lawrence_grading_scale)
GLP-1 (https://en.wikipedia.org/wiki/Glucagon-like_peptide-1) · AMPK (https://en.wikipedia.org/wiki/AMP-activated_protein_kinase)
Advanced glycation end-products (https://en.wikipedia.org/wiki/Advanced_glycation_end-product) · Infrapatellar (Hoffa's) fat pad (https://en.wikipedia.org/wiki/Infrapatellar_fat_pad)
Leptin (https://en.wikipedia.org/wiki/Leptin) · HOMA-IR (https://en.wikipedia.org/wiki/Homeostatic_model_assessment) · hs-CRP (https://en.wikipedia.org/wiki/C-reactive_protein)
Seronegative arthritis (https://en.wikipedia.org/wiki/Seronegative_arthropathy) · DMARDs (https://en.wikipedia.org/wiki/Disease-modifying_antirheumatic_drug)
FOLLOW US
The Show
Website: medicineredefined.com (https://medicineredefined.com)
Instagram / X: @medredefined (https://instagram.com/medredefined)
Dr. Altamash Raja
Instagram: @draltraja (https://instagram.com/draltraja)
LinkedIn: Altamash Raja (https://www.linkedin.com/in/altamash-raja-do-rmsk-cscs)
Refining Health & Performance (https://refininghealthrx.com)
Dr. Darsh Shah
Instagram: @doctor.darsh (https://www.instagram.com/doctor.darsh/)
LinkedIn: doctordarsh (https://www.linkedin.com/in/doctordarsh/)
Ready to stop guessing and start performing? Dr. Raja is now seeing patients through his telemedicine practice — limited founding member spots available at refininghealthrx.com (https://refininghealthrx.com).









